Twitter Facebook LinkedIn YouTube

New Listing: Newtopia Inc. (TSXV:NEWU)

Video Platform Video Management Video Solutions Video Player

Newtopia, a precision health company for habit change and disease prevention, takes a highly personalized, engaging and cost-effective approach to the maintenance of health and well-being.

Additional Information:

Company: Newtopia Inc.
Website: http://www.newtopia.com
Stock Symbol: TSXV: NEWU
Date Published: May 4, 2020
Transcript: Available

Video Transcript:

I’m Fiona Forbes for Investmentpitch Media

Newtopia Inc. is one of the latest new listings on the TSX Venture Exchange, trading under the symbol “NEWU”.

Newtopia, a precision health company for habit change and disease prevention, takes a highly personalized, engaging and cost-effective approach to the maintenance of health and well-being.

While many population and disease management companies in the U.S. today focus on either managing those with chronic disease or offering general wellness or engagement solutions to everyone, Newtopia’s platform solution specifically targets the population that is at-risk of developing a chronic disease.

In addition to biometric test outcomes, health risk assessments, claims or risk screener data, Newtopia uses genetic testing to help participants understand if they have any genetic factors that may have an impact on their weight and lifestyle and to personalize lifestyle recommendations by gaining a deeper understanding of how genes impact an individual’s ability to lose weight and reduce risk.

Prior to commercializing the platform in 2016, Newtopia participated in a randomized controlled trial funded by Aetna Inc. in order to validate the platform’s clinical and financial efficacy.

The study concluded that such programs, if implemented at scale and maintained, would be expected to produce additional marked beneficial effects on downstream risk factors and events such as hypertension, diabetes, myocardial infarction, stroke, and heart failure, along with their associated costs.

The three primary risk-bearing payors of these costs are large, self-insured employers that take on the full risk liability for their employees, private insurance companies that fully insure a specific population, and government funded payors including Medicare, Medicaid and Veterans Association.

Newtopia partners with insurers and employers, primarily in the U.S., and focuses its efforts on employees or members at risk of developing often preventable chronic diseases, such as obesity, type 2 diabetes, heart disease, stroke or fatty liver disease.

Each personalized program enables participants to sustainably reduce the five primary metabolic risk factors of chronic disease, including BMI, blood pressure, blood glucose, triglycerides and cholesterol, thereby delivering proven meaningful and growing healthcare risk reduction to individuals and cost savings to risk-bearing employers or insurers.

A Newtopia “Inspirator”, which is matched to an individual, based on individual personalities, meets regularly one-on-one by video, text, phone and email.

Newtopia’s customers are among Fortune 500 employers and insurers in the U.S. including a large pharmacy retail and health insurer, one of the largest financial services providers, a global consulting firm and an apparel manufacturing and retailer.

The company’s current contract base represents approximately 500,000 total employees of which roughly 50% are at-risk and eligible to participate in Newtopia’s platform.

The shares are trading at $060.

For more information, please visit the company’s website www.newtopia.com, contact Jeff Ruby, CEO and Founder, by email at jruby@newtopia.com.

I’m Fiona Forbes for Investmentpitch Media